These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 10516701
1. Bone mineral density after allogeneic bone marrow transplantation. Kauppila M, Irjala K, Koskinen P, Pulkki K, Sonninen P, Viikari J, Remes K. Bone Marrow Transplant; 1999 Oct; 24(8):885-9. PubMed ID: 10516701 [Abstract] [Full Text] [Related]
2. Recovery of bone mass and normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation. Kananen K, Volin L, Tähtelä R, Laitinen K, Ruutu T, Välimäki MJ. Bone Marrow Transplant; 2002 Jan; 29(1):33-9. PubMed ID: 11840142 [Abstract] [Full Text] [Related]
3. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Välimäki MJ, Kinnunen K, Volin L, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Ruutu T. Bone Marrow Transplant; 1999 Feb; 23(4):355-61. PubMed ID: 10100579 [Abstract] [Full Text] [Related]
4. Decreased bone mineral density is common after autologous blood or marrow transplantation. Schimmer AD, Mah K, Bordeleau L, Cheung A, Ali V, Falconer M, Trus M, Keating A. Bone Marrow Transplant; 2001 Aug; 28(4):387-91. PubMed ID: 11571512 [Abstract] [Full Text] [Related]
13. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study. Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F. Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559 [Abstract] [Full Text] [Related]
14. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation. Dodidou P, Bruckner T, Hosch S, Haass M, Klar E, Sauer P, Ziegler R, Leidig-Bruckner G. Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189 [Abstract] [Full Text] [Related]
15. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. Lormeau C, Soudan B, d'Herbomez M, Pigny P, Duquesnoy B, Cortet B. Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539 [Abstract] [Full Text] [Related]
17. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation. Abeş M, Sarihan H, Madenci E. J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110 [Abstract] [Full Text] [Related]
18. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. Perez EA, Josse RG, Pritchard KI, Ingle JN, Martino S, Findlay BP, Shenkier TN, Tozer RG, Palmer MJ, Shepherd LE, Liu S, Tu D, Goss PE. J Clin Oncol; 2006 Aug 01; 24(22):3629-35. PubMed ID: 16822845 [Abstract] [Full Text] [Related]
19. Bone mineral density in pediatric transplant recipients. Daniels MW, Wilson DM, Paguntalan HG, Hoffman AR, Bachrach LK. Transplantation; 2003 Aug 27; 76(4):673-8. PubMed ID: 12973107 [Abstract] [Full Text] [Related]
20. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis. Vlasiadis KZ, Damilakis J, Velegrakis GA, Skouteris CA, Fragouli I, Goumenou A, Matalliotakis J, Koumantakis EE. Maturitas; 2008 Mar 20; 59(3):226-33. PubMed ID: 18342460 [Abstract] [Full Text] [Related] Page: [Next] [New Search]